This drug may or may not be used in combination with aura. It is also indicated for treating cluster headache attacks. Imitrex injection drug should not be administered for treating hemiplegic. It should also not be used for managing basilar migraine. This injection reduces the symptoms and helps relieving the pain. It also cures various other symptoms of migraine including nausea, vomiting and sensitivity to sound or light.
Paediatric population under 18 years of age Sumatriptan is not recommended for use in children and adolescents as sumatriptan injection has not been studied in these age categories. Elderly over 65 Experience of the use of Sumatriptan in patients aged over 65 years is limited. The pharmacokinetics do not differ significantly from a younger population but, until further clinical data are available, the use of Sumatriptan in patients aged over 65 years is not recommended.
Method of administration Sumatriptan SUN should be injected subcutaneously using a pre-filled pen. By pressing and immediately releasing the blue button a first click sound is heard indicating that the dose is started. The pen must be kept pressed onto the skin until a second click is heard. This indicates that the dose is completed. Now the pen can be lifted off the skin. The safety needle cover of the pen will automatically extend to cover the needle.
The inspection window will be blue confirming that the injection is complete. Patients should be advised to strictly observe the instruction leaflet for Sumatriptan SUN especially regarding the use of the pre-filled pen. Sumatriptan should not be given to patients who have had myocardial infarction or have ischaemic heart disease, coronary vasospasm Prinzmetal's angina , peripheral vascular disease or patients who have symptoms or signs consistent with ischaemic heart disease.
Sumatriptan should not be administered to patients with a history of cerebovascular accident CVA or transient ischaemic attack TIA. Sumatriptan should not be administered to patients with severe hepatic impairment. The use of sumatriptan in patients with moderate and severe hypertension and mild uncontrolled hypertension is contraindicated.
Concurrent administration of monoamine oxidase inhibitors and sumatriptan is contraindicated. Sumatriptan must not be used within two weeks of discontinuation of therapy with monoamine oxidase inhibitors see section 4. Sumatriptan SUN should only be used where there is a clear diagnosis of migraine or cluster headache.
Sumatriptan is not indicated for use in the management of hemiplegic, basilar or opthalmoplegic migraine. The recommended doses of Sumatriptan should not be exceeded. This medicinal product contains less than 1 mmol sodium 23mg per dose, i. Sumatriptan should not be given intravenously, because of its potential to cause vasospasm.
The vasospasm may result in arrhythmias, ischaemic ECG changes or myocardial infarction. Before treating headaches in patients not previously diagnosed as migraineurs, and in migraineurs who present with atypical symptoms, care should be taken to exclude other potentially serious neurological conditions. It should be noted that migraineurs may be at risk of certain cerebrovascular events e.
Following administration, sumatriptan can be associated with transient symptoms including chest pain and tightness which may be intense and involve the throat. Where such symptoms are thought to indicate ischaemic heart disease, no further doses of sumatriptan should be given and appropriate evaluation should be carried out.
Sumatriptan should not be given to patients with risk factors for ischaemic heart disease, including those patients who are heavy smokers or users of nicotine substitution therapies, without prior cardiovascular evaluation see section 4.
Special consideration should be given to postmenopausal women and males over 40 with these risk factors. These evaluations however, may not identify every patient who has cardiac disease and, in very rare cases, serious cardiac events have occurred in patients without underlying cardiovascular disease see section 4. If the patient experiences symptoms which are severe or persistent or are consistent with angina, further doses should not be taken until appropriate investigations have been carried out to check for the possibility of ischaemic changes.
Sumatriptan should be administered with caution to patients with mild controlled hypertension, since transient increases in blood pressure and peripheral vascular resistance have been observed in a small proportion of patients see section 4. There have been rare post-marketing reports describing patients with serotonin syndrome including altered mental status, autonomic instability and neuromuscular abnormalities following the use of a selective serotonin reuptake inhibitor SSRI and sumatriptan.
Prompt treatment allows you to get back to your normal routine and may decrease your need for other pain medications. Sumatriptan belongs to a group of drugs called triptans.
It affects a certain natural chemical serotonin that constricts blood vessels in the brain. It may also block other pain pathways in the brain. How to use Imitrex Pen Injector Read the Patient Information Leaflet available from your pharmacist before you start using sumatriptan and each time you get a refill.
Ask your doctor or pharmacist if you have any questions. You have literally saved my life! Prepay online to lock in your savings. Bring your prescription to a participating pharmacy and have them fill it, as usual. At pickup, show the pharmacist your Blink Card, and have them process it as the primary payor. Do I need a prescription? Even though Blink does not need a copy of your prescription, you must have a valid prescription from the doctor to pick up at the pharmacy. Does my pharmacy accept Blink?
Local pharmacies serving every community accept Blink, including Walmart, Albertsons, Kroger, Kmart and many more.
Tags: nexium card canada medical abortion mifeprex misoprostol t�c dỴng thuốc misoprostol stada
© Copyright 2017 Imitrex statdose pen price. www.quikitdept.com.